The Digital Lab at Novartis has a human- centric approach

Novartis Paperless Lab Academy 2021

At the PLA2021 Europe, we´ll have the great opportunity to discover how Novartis is approaching their digital journey. More precisely at the R&D department directly from Vijay Raju, Global Head Analytical R&D based in Basel, Switzerland.

Digital Lab: A human-centric design approach to transform ways of working

Vijay has to ensure the correct execution and meet the deliverables dates expected from his team across a broad spectrum of application from small molecules, biologicals to biosimilars. Their technical R&D key accountabilities are about creating but also innovating technical product designs and processes and  supplying clinical and preclinical study materials.

Novartis aspires to build a leading medicines company, powered by advanced therapy platforms and data science. In this direction, the Technical R&D organisation within Novartis is implementing its vision for a digital lab allowing scientists to focus on real science and transforming their way of working, explain Vijay to our PLA event manager.

The presentation will provide an overview of the user centric approach pursued in engaging the scientists to understand their pain points, defining future solutions and designing the prototypes.

The overarching end-to-end design architecture and overview of some of the solutions under implementation will be presented.

FAIR PRINCIPLESThe solutions include a Digital Integration Hub enabling data to become FAIR  – Findable, Accessible, Interoperable and Reusable. Introduction to the FAIR principles.

At Novartis, data as such create knowledge and provide insights enabling digital twins, predictive analytics and process automation. The presentation includes use cases that will apply these capabilities to accelerate technical development, transform knowledge management and
increase efficiency in operations will be shared.

Additionally, a very smart approach is implementing ensuring the buy-in of the laboratory users. Through a digital pilot laboratory which everyone can visualise the new processes to be implemented, they get user acceptance before full scale implementation. 

In conclusion, the anticipated benefits to the  scientific community and business will be outlined.

Novartis Paperless Lab Academy
Vijay Raju, Global Head of Analytical R&D at Novartis AG.
His team is responsible for the analytical strategy, operations, and project management in support of an industry leading NCE portfolio. He is also the sponsor of the data & digital transformation efforts in the CMC area with specific focus on the labs and data strategy. Vijay has an MBA and MS in Chemical Engineering.


Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world.


Paperless Lab Academy 2021 EUROPE


Latest Posts

PLA2023USA: Mastering your Data Management

In a data-driven world, companies that succeed in gaining actionable insights through data management will be able to innovate faster, develop better

Read More

18 October 2023

PLA2023USA: Use Cases of Advanced Lab Digitalization

In an era dominated by technological innovation, the implementation of a laboratory information management system (LIMS) is one of the most important

Read More

13 October 2023

PLA2023USA: Adopting an Ecosystem Mindset for Successful Digital Transformation

The advent of Industry 4.0 technologies, such as the Internet of Things (IoT), Big Data analytics, artificial intelligence (AI), and advanced robotics

Read More

06 October 2023